- Home
- TARA vs OFS Comparison
TARA vs OFS Comparison
Compare TARA & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- OFS
- Stock Information
- Founded
- TARA N/A
- OFS 2001
- Country
- TARA United States
- OFS United States
- Employees
- TARA N/A
- OFS N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- OFS Finance/Investors Services
- Sector
- TARA Health Care
- OFS Finance
- Exchange
- TARA Nasdaq
- OFS Nasdaq
- Market Cap
- TARA 118.1M
- OFS 117.0M
- IPO Year
- TARA N/A
- OFS 2012
- Fundamental
- Price
- TARA $5.02
- OFS $7.55
- Analyst Decision
- TARA Strong Buy
- OFS
- Analyst Count
- TARA 6
- OFS 0
- Target Price
- TARA $19.80
- OFS N/A
- AVG Volume (30 Days)
- TARA 723.1K
- OFS 72.0K
- Earning Date
- TARA 11-11-2025
- OFS 10-30-2025
- Dividend Yield
- TARA N/A
- OFS 17.75%
- EPS Growth
- TARA N/A
- OFS N/A
- EPS
- TARA N/A
- OFS 0.76
- Revenue
- TARA N/A
- OFS $43,337,000.00
- Revenue This Year
- TARA N/A
- OFS N/A
- Revenue Next Year
- TARA N/A
- OFS N/A
- P/E Ratio
- TARA N/A
- OFS $10.02
- Revenue Growth
- TARA N/A
- OFS N/A
- 52 Week Low
- TARA $1.60
- OFS $7.52
- 52 Week High
- TARA $10.48
- OFS $9.80
- Technical
- Relative Strength Index (RSI)
- TARA 74.50
- OFS 31.46
- Support Level
- TARA $4.81
- OFS $7.54
- Resistance Level
- TARA $5.12
- OFS $7.81
- Average True Range (ATR)
- TARA 0.35
- OFS 0.20
- MACD
- TARA 0.10
- OFS -0.05
- Stochastic Oscillator
- TARA 86.70
- OFS 9.78
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.